Shilpa Mehta
Pediatric Endocrinology · Brooklyn, NYNPI 1255743365
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations.
Across 161 payments — averaging $28.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- Ascendis Pharma Endocrinology Inc$582
- Novo Nordisk$452
- Tolmar, Inc.$403
- Sanofi-aventis U.S. LLC$360
- Insulet Corporation$338
- plus $2K from 23 others
Across 7 payments — averaging $722.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4K
- Biomarin Pharmaceutical Inc.$1K
What the payments were for
- Food & beverage$4,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $727 |
| Ascendis Pharma Endocrinology Inc | 17 | $582 |
| Novo Nordisk | 15 | $452 |
| Tolmar, Inc. | 15 | $403 |
| Sanofi-aventis U.S. LLC | 8 | $360 |
| Insulet Corporation | 8 | $338 |
| Pfizer | 5 | $326 |
| Amneal Pharmaceuticals LLC | 7 | $160 |
| Tandem Diabetes Care, Inc. | 5 | $153 |
| Azurity Pharmaceuticals, Inc. | 8 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $128 |
| Neurocrine Biosciences, Inc. | 3 | $99 |
| Endo USA, Inc. | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| Tolmar Pharmaceuticals, Inc. | 4 | $81 |
| Abbott | 3 | $71 |
| Endo Pharmaceuticals Inc. | 4 | $70 |
| Dexcom, Inc. | 3 | $57 |
| Kyowa Kirin, Inc. | 2 | $56 |
| Eton Pharmaceuticals, Inc. | 1 | $43 |
| QOL Medical, LLC | 2 | $43 |
| Soleno Therapeutics, Inc. | 1 | $35 |
| AstraZeneca | 1 | $31 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Companion Medical, Inc. | 1 | $25 |
| Medtronic(2 entities) | 2 | $23 |
| Ascensia Diabetes Care US Inc. | 1 | $23 |
| Intuity Medical Inc | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,666 in reported general payments places this provider in the 75th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Brooklyn
- Manjula ChatterjeeBrooklyn$3K
- Vivian ChinBrooklyn$1K
- Paul SaengerMineola$180K
- Alicia RomanoSleepy Hollow$157K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Moris AnguloMineola$73K
- Jill BrodskyPoughkeepsie$45K
- Jorge Mejia-CorlettoNorth Babylon$44K
- Angela VerardoBronx$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.